RKDA

#5118
Arcadia Biosciences, Inc.
1.33 USD
+0.76%
Sector: Valores de Consumo Defensivo
Básica: USD
Divisa de beneficio: USD
Rango diario
1.33
1.34
Rango anual
1.30
6.71
Cambio diario
+0.76%
Variación mensual
-26.11%
Variación en los últimos 6 meses
-74.47%
Cambio anual
-58.44%
Cierres anteriores
1.32
Abrir
1.34
Bid
Ask
Mínimo
1.33
High
1.34
Volumen
2
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 2.74 M
  • Employee 8
  • Founded 2002
  • CEO N/A
  • Website www.arcadiabio.com
  • Headquarter Delaware, United States
  • FIGI BBG000GYBX66
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.16
Relación precio/flujo de caja
0.53

Arcadia Biosciences Inc

Arcadia Biosciences is a publicly traded American agricultural biotechnology headquartered in Davis, California focused on the development of traits to enhance crop quality and productivity. The company is partly owned by Moral Compass Corporation. It has developed a reduced-gluten and enhanced starch variety of wheat under the name GoodWheat. Arcadia also has a joint venture with Bioceres called Verdeca, which has developed and is commercializing HB4 technology in soybeans that gained FDA approval in 2017. HB4 soybeans have increased yield up to 30% while being more resistant to abiotic stress such as drought.

Noticias